Editorial: Appraising liver fibrosis with eagle eyes

Grace Lai-Hung Wong^{1

2

3}

Affiliations

¹ Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China.
² Medical Data Analytics Centre (MDAC), The Chinese University of Hong Kong, Hong Kong SAR, China.
³ Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

Editorial

Grace Lai-Hung Wong. J Gastroenterol Hepatol. 2023 Mar.

. 2023 Mar;38(3):343.

doi: 10.1111/jgh.16146.

Grace Lai-Hung Wong^{1

2

3}

¹ Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China.
² Medical Data Analytics Centre (MDAC), The Chinese University of Hong Kong, Hong Kong SAR, China.
³ Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

No abstract available

Comment on

A bibliometric and visualized analysis of liver fibrosis from 2002 to 2022.
Zhao Q, Liang L, Zhai F, Ling G, Xiang R, Jiang X. Zhao Q, et al. J Gastroenterol Hepatol. 2023 Mar;38(3):359-369. doi: 10.1111/jgh.16081. Epub 2022 Dec 12. J Gastroenterol Hepatol. 2023. PMID: 36459993 Review.

1. Wong GL. Non-invasive assessments for liver fibrosis - the crystal ball we long for. J. Gastroenterol. Hepatol. 2018; 33: 1009-1015.
1. Zhao Q, Liang L, Zhai F, Ling G, Xiang R, Jiang X. A bibliometric and visualized analysis of liver fibrosis from 2002 to 2022. J. Gastroenterol. Hepatol. 2023; 38: 359-369.
1. Wong GL, Yuen PC, Ma AJ, Chan AWH, Leung HHW, Wong VWS. Artificial intelligence in prediction of non-alcoholic fatty liver disease and fibrosis. J. Gastroenterol. Hepatol. 2021; 36: 543-550.
1. Wong VW, Adams LA, de Ledinghen V et al. Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. Nat. Rev. Gastroenterol. Hepatol. 2018; 15: 461-478.
1. Angulo P, Kleiner DE, Dam-Larsen S et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2015; 149: 389-97.e10.